TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624909. A total of 5 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,769 | +104.5% | 859,700 | +51.0% | 0.12% | +87.1% |
| Q2 2023 | $4,288 | -60.6% | 569,400 | -53.7% | 0.06% | -65.7% |
| Q1 2023 | $10,880 | +11.2% | 1,229,400 | +14.6% | 0.18% | -17.0% |
| Q4 2022 | $9,788 | -99.9% | 1,073,200 | -12.6% | 0.22% | +0.9% |
| Q3 2022 | $9,912,000 | +13.8% | 1,228,300 | +6.1% | 0.22% | +13.1% |
| Q2 2022 | $8,710,000 | +25.7% | 1,158,200 | +57.0% | 0.19% | +94.9% |
| Q1 2022 | $6,929,000 | -42.7% | 737,900 | -51.1% | 0.10% | -37.2% |
| Q4 2021 | $12,086,000 | -11.2% | 1,508,900 | +10.5% | 0.16% | -14.3% |
| Q3 2021 | $13,615,000 | +314.2% | 1,365,600 | +311.3% | 0.18% | +237.0% |
| Q2 2021 | $3,287,000 | +2.1% | 332,000 | +19.0% | 0.05% | +5.9% |
| Q1 2021 | $3,220,000 | +138.2% | 279,000 | +99.1% | 0.05% | +218.8% |
| Q4 2020 | $1,352,000 | -63.9% | 140,100 | -65.3% | 0.02% | -72.4% |
| Q3 2020 | $3,747,000 | -9.3% | 403,300 | +20.3% | 0.06% | -44.8% |
| Q2 2020 | $4,133,000 | +58.4% | 335,200 | +25.9% | 0.10% | +5.0% |
| Q4 2019 | $2,610,000 | +130.6% | 266,300 | +61.9% | 0.10% | +96.1% |
| Q3 2019 | $1,132,000 | +106.6% | 164,500 | +176.9% | 0.05% | +104.0% |
| Q2 2019 | $548,000 | -28.6% | 59,400 | +21.2% | 0.02% | -41.9% |
| Q1 2019 | $768,000 | – | 49,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delek Group, Ltd. | 780,000 | $13,330,000 | 0.68% |
| GROUP ONE TRADING, L.P. | 1,121,300 | $19,163,000 | 0.19% |
| SIMPLEX TRADING, LLC | 1,651 | $135,000 | 0.01% |
| JPMORGAN CHASE & CO | 500,000 | $8,545,000 | 0.00% |